Project Grant R36DA065924
- Federal Grant Award Summary The University of Maryland, College Park received a $107,090 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 15, 2026, with a completion date of February 14, 2028. This research initiative will generate longitudinal, person-centered data characterizing the interplay between perinatal substance use (PSU) and perinatal depression (PD) and their combined impact on infant...
- Grant Award Summary The University of Maryland, College Park received a $183,873 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to implement and evaluate the Youth Substance Use Unit (YSU)—a school-based partnership model delivering substance use disorder treatment services to rural adolescents. The award, effective May 15, 2026 through April 30, 2031, funds a K23 research career development study examining...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $219,291 to the University of Maryland, Baltimore under the Drug Use and Addiction Research Programs (CFDA 93.279) for the Integrated Services for People Who Inject Drugs (PWID) using Person-centered Interactions, Reach, and Engagement (INSPIRE) study. Awarded on September 30, 2025, with an ultimate completion date of July 31, 2028, this implementation science project will develop and evaluate an integrated collaborative...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, Baltimore $1.924 million under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct basic and translational neuroscience research on the behavioral and neurobiological mechanisms of reciprocal social interactions in substance use disorders (SUDs). The project, which commenced July 15, 2025, and extends through March 31, 2030, develops and implements an innovative animal...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, Baltimore a $2.21 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period September 1, 2025 through May 31, 2030. The award supports joint decomposition analysis of multi-omic datasets to explore the impact of substance use disorders (SUD) and human immunodeficiency virus (HIV) on reward circuitry and neuroinflammation in the brain. The...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded University of Maryland, Baltimore $685,937 under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 15, 2026, with a project completion date of December 31, 2030. This Project Grant funds research investigating the impact of opioid use disorder (OUD) on mitochondrial dysfunction among antiretroviral therapy (ART)-receiving aging people with HIV (PWH). The research addresses a critical gap in understanding...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of California, San Diego $2,312,059 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2025, for a five-year project period extending through April 30, 2030. The grant supports "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," a hybrid Type I clinical trial designed to identify and engage...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, College Park $248,717 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support fundamental neuroscience research investigating the neural mechanisms underlying cognitive learning and decision-making. The project, titled "Probing the Mechanisms and Circuits Underlying Orbitofrontal Signaling," operates from August 1, 2025, through July 31, 2028, and...
- Federal Grant Award Summary The University of Michigan received a $170,744 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 17, 2025, with a completion date of December 31, 2025. This research initiative investigates the glucocorticoid receptor (GR) as a neuromolecular mechanism underlying inhibitory control deficits associated with substance use disorder (SUD). The project examines how the GR...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded The Johns Hopkins University a $198,164 Project Grant effective October 17, 2025, through May 14, 2027, to conduct research on improving access and linkage to substance use treatment for formerly incarcerated individuals. The project applies a complex systems approach to address barriers to Medications for Opioid Use Disorder (MOUD)...
The University of Maryland, College Park received a $107,386 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a single-session, peer-delivered internalized stigma reduction intervention for individuals with polysubstance use in rural Maryland. The award, dated May 15, 2026, with completion targeted for April 30, 2028, addresses the disproportionate burden of opioid and stimulant use in rural communities and the substantial barriers to treatment engagement and retention posed by internalized stigma surrounding substance use disorder and medication for opioid use disorder. The intervention leverages Peer Recovery Specialists—individuals with lived experience in substance use disorder and recovery—to deliver a brief, evidence-based stigma reduction approach based on Acceptance and Commitment Therapy principles, tailored specifically for resource-constrained rural settings where access to such interventions is limited. This project aligns with NIDA's core mission to develop new knowledge and approaches for prevention, diagnosis, and treatment of drug use, misuse, and addiction through implementation research. By combining peer-delivered services with evidence-based therapeutic techniques in a brief, scalable format, the research seeks to reduce internalized stigma and its associated negative consequences, thereby improving treatment engagement, retention, and sustained recovery outcomes for underserved rural populations experiencing polysubstance use.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $107.4k | 5/1/26 |